Exosomal cell-to-cell transmission of alpha synuclein oligomers.

Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci (2015) 2.38

Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models. Hum Mol Genet (2013) 1.94

Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med (2014) 1.85

Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci (2015) 1.53

shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity. PLoS Genet (2016) 1.40

Transmission of α-synucleinopathy from olfactory structures deep into the temporal lobe. Mol Neurodegener (2016) 1.40

Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol (2015) 1.37

Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity. J Clin Invest (2014) 1.37

Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep (2012) 1.36

Exosomes and autophagy: coordinated mechanisms for the maintenance of cellular fitness. Front Immunol (2014) 1.24

LRRK2 secretion in exosomes is regulated by 14-3-3. Hum Mol Genet (2013) 1.15

Exosomes as mediators of neuroinflammation. J Neuroinflammation (2014) 1.12

Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models. J Neurosci (2014) 1.11

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol (2014) 1.10

Mapping the subcellular distribution of α-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson's disease pathogenesis. J Neurosci (2013) 1.09

Neuronal aggregates: formation, clearance, and spreading. Dev Cell (2015) 1.09

Extracellular monomeric tau protein is sufficient to initiate the spread of tau protein pathology. J Biol Chem (2013) 1.07

Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies. Pharmacol Ther (2013) 1.06

Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis. PLoS One (2013) 1.05

Acceleration of α-synuclein aggregation by exosomes. J Biol Chem (2014) 1.04

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies. Brain (2015) 1.03

Hijacking multivesicular bodies enables long-term and exosome-mediated long-distance action of anthrax toxin. Cell Rep (2013) 1.01

Alpha-synuclein and tau: teammates in neurodegeneration? Mol Neurodegener (2014) 1.00

Thinking laterally about neurodegenerative proteinopathies. J Clin Invest (2013) 0.99

Membrane remodeling by α-synuclein and effects on amyloid formation. J Am Chem Soc (2013) 0.99

Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors. Nat Rev Neurol (2015) 0.98

Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein. Dis Model Mech (2014) 0.98

TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol (2015) 0.97

The role of extracellular vesicles in the progression of neurodegenerative disease and cancer. Trends Mol Med (2014) 0.97

Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment. Autophagy (2014) 0.96

DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity. Toxicol Sci (2015) 0.95

Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein. Nat Commun (2014) 0.94

Impaired intracellular trafficking defines early Parkinson's disease. Trends Neurosci (2015) 0.94

Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Parkinsons Dis (2015) 0.93

Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases. Dis Model Mech (2014) 0.92

Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol (2015) 0.92

Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation. Acta Neuropathol (2015) 0.90

Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization. Ann Neurol (2014) 0.90

Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics. ACS Chem Neurosci (2013) 0.89

Direct detection of alpha synuclein oligomers in vivo. Acta Neuropathol Commun (2013) 0.89

ATP13A2/PARK9 regulates secretion of exosomes and α-synuclein. J Neurosci (2014) 0.88

Mutation of SIMPLE in Charcot-Marie-Tooth 1C alters production of exosomes. Mol Biol Cell (2013) 0.88

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy. Mol Neurodegener (2015) 0.88

Prion-like propagation of protein aggregation and related therapeutic strategies. Neurotherapeutics (2013) 0.88

Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology. J Neurochem (2016) 0.88

Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders. Sci Signal (2015) 0.87

Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology (2014) 0.87

Extracellular vesicles and intercellular communication within the nervous system. J Clin Invest (2016) 0.87

Extracellular Vesicles and a Novel Form of Communication in the Brain. Front Neurosci (2016) 0.86

Knockdown of Autophagy Inhibits Infectious Hepatitis C Virus Release by the Exosomal Pathway. J Virol (2015) 0.86

Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends Cell Biol (2016) 0.85

The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease. Neuroscience (2014) 0.85

Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex. Virology (2015) 0.85

Identification of distinct circulating exosomes in Parkinson's disease. Ann Clin Transl Neurol (2015) 0.84

Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease. Int J Mol Sci (2016) 0.84

The Interplay between Alpha-Synuclein Clearance and Spreading. Biomolecules (2015) 0.84

Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury. Acta Neuropathol Commun (2015) 0.84

Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD. Cell Rep (2016) 0.84

Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease. Front Neurosci (2015) 0.84

Sequence-dependent internalization of aggregating peptides. J Biol Chem (2014) 0.82

Legal but lethal: functional protein aggregation at the verge of toxicity. Front Cell Neurosci (2015) 0.81

Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1. Acta Neuropathol Commun (2014) 0.81

Neuronal exosomes facilitate synaptic pruning by up-regulating complement factors in microglia. Sci Rep (2015) 0.81

Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice. Hum Mol Genet (2014) 0.81

Organizing polarized delivery of exosomes at synapses. Traffic (2015) 0.81

The associations between Parkinson's disease and cancer: the plot thickens. Transl Neurodegener (2015) 0.81

α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities. Cell Mol Neurobiol (2016) 0.80

Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies. Expert Opin Ther Targets (2015) 0.80

Molecular details of α-synuclein membrane association revealed by neutrons and photons. J Phys Chem B (2015) 0.80

Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons. Acta Neuropathol (2016) 0.80

Exosomes in the Pathology of Neurodegenerative Diseases. J Biol Chem (2016) 0.79

Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. Nat Rev Neurol (2016) 0.79

Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases. Neurotherapeutics (2013) 0.79

Human-to-mouse prion-like propagation of mutant huntingtin protein. Acta Neuropathol (2016) 0.78

Tetherin is an exosomal tether. Elife (2016) 0.78

Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders. Front Neurosci (2016) 0.78

Membrane remodeling and mechanics: Experiments and simulations of α-Synuclein. Biochim Biophys Acta (2016) 0.78

Transmission of Soluble and Insoluble α-Synuclein to Mice. J Neuropathol Exp Neurol (2015) 0.78

Interactions between calcium and alpha-synuclein in neurodegeneration. Biomolecules (2014) 0.78

Exosomes as Novel Regulators of Adult Neurogenic Niches. Front Cell Neurosci (2016) 0.78

Impact of lysosome status on extracellular vesicle content and release. Ageing Res Rev (2016) 0.78

α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients. Sci Rep (2017) 0.78

Histones facilitate α-synuclein aggregation during neuronal apoptosis. Acta Neuropathol (2016) 0.78

Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease. Small GTPases (2016) 0.77

Is Parkinson's disease truly a prion-like disorder? An appraisal of current evidence. Neurol Res Int (2015) 0.77

Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction. Neurobiol Aging (2014) 0.77

α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease. Hum Mol Genet (2016) 0.77

Horizontal Transmission of Cytosolic Sup35 Prions by Extracellular Vesicles. MBio (2016) 0.76

Disease-modifying therapeutic directions for Lewy-Body dementias. Front Neurosci (2015) 0.76

The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity. Proc Natl Acad Sci U S A (2016) 0.76

Emerging roles of extracellular vesicles in neurodegenerative disorders: focus on HIV-associated neurological complications. Cell Death Dis (2016) 0.76

Potential Modes of Intercellular α-Synuclein Transmission. Int J Mol Sci (2017) 0.76

Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy. Neuropathol Appl Neurobiol (2016) 0.76

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med (2017) 0.76

Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections. Acta Neuropathol (2016) 0.76

Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors. Cell Mol Neurobiol (2016) 0.76

Disease-Toxicant Interactions in Parkinson's Disease Neuropathology. Neurochem Res (2016) 0.76

Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth. Sci Rep (2015) 0.75

The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener (2017) 0.75

A Rapid, Semi-Quantitative Assay to Screen for Modulators of Alpha-Synuclein Oligomerization Ex vivo. Front Neurosci (2016) 0.75

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10

A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03

Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature (2005) 31.60

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30

Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18

Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet (2005) 15.96

Exosomes: composition, biogenesis and function. Nat Rev Immunol (2002) 13.99

Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol (2006) 13.29

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol (2004) 9.62

Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct (1998) 9.18

Potential therapeutic applications of autophagy. Nat Rev Drug Discov (2007) 8.56

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol (2008) 7.86

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet (2004) 7.69

Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science (2007) 7.15

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A (2009) 6.87

Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem (2003) 6.84

Exosomes: extracellular organelles important in intercellular communication. J Proteomics (2010) 6.47

Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia (2006) 6.45

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science (2000) 6.28

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science (2001) 6.15

Exosomes: a common pathway for a specialized function. J Biochem (2006) 5.79

Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem (1998) 5.79

Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol (2004) 5.71

Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci (2000) 5.57

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A (2007) 5.50

Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci (2001) 5.32

Cells release prions in association with exosomes. Proc Natl Acad Sci U S A (2004) 5.17

Clustering and conservation patterns of human microRNAs. Nucleic Acids Res (2005) 4.79

Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics (2009) 4.27

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A (2009) 4.00

Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A (2006) 3.98

Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci (2005) 3.93

Exosomes: from biogenesis and secretion to biological function. Immunol Lett (2006) 3.82

Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci (2010) 3.81

A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods (2006) 3.73

The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron (2009) 3.68

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J (2005) 3.60

Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A (2009) 3.47

Phospholipid model membranes. I. Structural characteristics of hydrated liquid crystals. Biochim Biophys Acta (1967) 3.29

Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci (2007) 3.16

Exosomes are released by cultured cortical neurones. Mol Cell Neurosci (2006) 3.07

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res (2008) 3.01

Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J (2006) 2.96

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol (2002) 2.92

MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res (2008) 2.90

A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem (2007) 2.89

Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem (2008) 2.86

Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol (2008) 2.78

Lipid raft-associated protein sorting in exosomes. Blood (2003) 2.76

Identification of clustered microRNAs using an ab initio prediction method. BMC Bioinformatics (2005) 2.76

Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci (2004) 2.65

Revealing global regulatory perturbations across human cancers. Mol Cell (2009) 2.62

Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci U S A (2009) 2.61

Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature (2003) 2.60

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol (2008) 2.56

Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta (1999) 2.55

Exosomes biological significance: A concise review. Blood Cells Mol Dis (2006) 2.46

Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One (2008) 2.35

The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci U S A (2007) 2.34

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis (2011) 2.32

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol (2008) 2.31

Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol (2007) 2.31

Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol (2007) 2.30

Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med (2011) 2.10

Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells. Traffic (2007) 2.10

Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J (2010) 1.90

Degradation of alpha-synuclein by proteasome. J Biol Chem (1999) 1.87

miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res (2008) 1.87

Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J Cell Biochem (2010) 1.80

Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem (2004) 1.79

microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells. Blood (2009) 1.75

Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol (2008) 1.74

Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci U S A (2006) 1.73

MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One (2009) 1.70

Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem (2009) 1.67

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol (1998) 1.67

A combinatorial code for the interaction of alpha-synuclein with membranes. J Biol Chem (2005) 1.60

Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J Neurochem (2007) 1.55

Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J Biol Chem (2001) 1.48

CHIP targets toxic alpha-Synuclein oligomers for degradation. J Biol Chem (2008) 1.43

miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Blood (2010) 1.41

Identification of new central nervous system specific mouse microRNAs. FEBS Lett (2006) 1.40

Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity. J Pharmacol Exp Ther (2009) 1.38

Plasma membrane targetting, vesicular budding and release of galectin 3 from the cytoplasm of mammalian cells during secretion. J Cell Sci (1997) 1.35

A cDNA library functional screening strategy based on fluorescent protein complementation assays to identify novel components of signaling pathways. Methods (2004) 1.33

miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett (2010) 1.32

Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein. J Biol Chem (2001) 1.28

Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Int J Cancer (2010) 1.27

Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide. Life Sci (2009) 1.23

Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein. J Neurosci (2009) 1.21

Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett (2009) 1.10

MicroRNAs: novel therapeutic targets in neurodegenerative diseases. Drug Discov Today (2009) 1.09

Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein. Exp Gerontol (2006) 1.07

Depth of α-synuclein in a bilayer determined by fluorescence, neutron reflectometry, and computation. Biophys J (2012) 1.06

The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of α-synuclein. PLoS One (2011) 1.06

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev (2010) 6.35

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell (2011) 6.23

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science (2007) 5.49

Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci (2005) 4.71

Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity. J Biol Chem (2004) 2.62

Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. J Neurosci (2011) 2.53

Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One (2008) 2.35

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol (2008) 2.31

Retracted SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. J Neurosci (2012) 2.00

Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J (2010) 1.90

The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem (2005) 1.85

Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci U S A (2006) 1.73

Photoperiod- and thermo-sensitive genic male sterility in rice are caused by a point mutation in a novel noncoding RNA that produces a small RNA. Cell Res (2012) 1.63

Converse modulation of toxic alpha-synuclein oligomers in living cells by N'-benzylidene-benzohydrazide derivates and ferric iron. Biochem Biophys Res Commun (2009) 1.63

Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia. Hum Mol Genet (2008) 1.62

Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J Neurochem (2007) 1.55

Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol (2008) 1.45

CHIP targets toxic alpha-Synuclein oligomers for degradation. J Biol Chem (2008) 1.43

α-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol (2012) 1.42

Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity. J Pharmacol Exp Ther (2009) 1.38

Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. FASEB J (2006) 1.35

Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J Clin Invest (2009) 1.35

Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem Biophys Res Commun (2006) 1.32

A review of independent component analysis application to microarray gene expression data. Biotechniques (2008) 1.24

Autophagic substrate clearance requires activity of the syntaxin-5 SNARE complex. J Cell Sci (2011) 1.23

Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiol Dis (2007) 1.22

Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5). PLoS One (2011) 1.21

Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J Biol Chem (2010) 1.20

Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system. J Neurochem (2009) 1.18

Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease. J Neuropathol Exp Neurol (2009) 1.15

Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp Neurol (2005) 1.14

Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease. Proc Natl Acad Sci U S A (2011) 1.08

Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol (2012) 1.07

Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS One (2013) 1.06

Characterization of oligomer formation of amyloid-beta peptide using a split-luciferase complementation assay. J Biol Chem (2011) 1.05

Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway. J Biol Chem (2006) 1.04

In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility. PLoS One (2010) 1.02

Proteotoxicity and cardiac dysfunction. N Engl J Med (2013) 1.00

Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway. Autophagy (2012) 1.00

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients. Acta Neuropathol (2014) 1.00

Metal exposure and Alzheimer's pathogenesis. J Struct Biol (2006) 0.98

Alpha-synuclein and chaperones in dementia with Lewy bodies. J Neuropathol Exp Neurol (2005) 0.98

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease. Acta Neuropathol Commun (2015) 0.94

A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity. Biochem Biophys Res Commun (2004) 0.93

Dopamine-induced conformational changes in alpha-synuclein. PLoS One (2009) 0.93

BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8. Mol Cell Biol (2012) 0.92

Independent component analysis of Alzheimer's DNA microarray gene expression data. Mol Neurodegener (2009) 0.92

Alpha-synuclein's degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease. Autophagy (2012) 0.91

Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization. Ann Neurol (2014) 0.90

Novel computational identification of highly selective biomarkers of pollutant exposure. Environ Sci Technol (2011) 0.90

Direct detection of alpha synuclein oligomers in vivo. Acta Neuropathol Commun (2013) 0.89

No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Acta Neuropathol (2006) 0.88

Development and screening of contrast agents for in vivo imaging of Parkinson's disease. Mol Imaging Biol (2013) 0.87

Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease. PLoS One (2010) 0.82

Molecular chaperones and co-chaperones in Parkinson disease. Neuroscientist (2012) 0.82

Molecular chaperones in Parkinson's disease--present and future. J Parkinsons Dis (2011) 0.80

Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies. Expert Opin Ther Targets (2015) 0.80

Assessment of gene order computing methods for Alzheimer's disease. BMC Med Genomics (2013) 0.79

Studying protein degradation pathways in vivo using a cranial window-based approach. Methods (2010) 0.79

A three-dimensional tissue culture model of bone formation utilizing rotational co-culture of human adult osteoblasts and osteoclasts. Acta Biomater (2013) 0.78

Transmission of Soluble and Insoluble α-Synuclein to Mice. J Neuropathol Exp Neurol (2015) 0.78

Increased expression of TrkB and Capzb2 accompanies preserved cognitive status in early Alzheimer disease pathology. J Neuropathol Exp Neurol (2012) 0.78

Drug targets from genetics: α-synuclein. CNS Neurol Disord Drug Targets (2011) 0.78

A special local clustering algorithm for identifying the genes associated with Alzheimer's disease. IEEE Trans Nanobioscience (2010) 0.77

Corrigendum: Laterodorsal tegmentum interneuron subtypes oppositely regulate olfactory cue-induced innate fear. Nat Neurosci (2016) 0.75

Systems biology of neurodegenerative diseases. Integr Biol (Camb) (2015) 0.75

[Misdiagnosis of branchio-oto-renal syndrome as preauricular fistula: report of two cases]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.75

[Clinical analysis of facial nerve decompression on the treatment of facial paralysis]. Lin Chuang Er Bi Yan Hou Ke Za Zhi (2006) 0.75

Photo-Induced Superhydrophilicity of Anatase TiO Surface Uncovered by First-Principles Molecular Dynamics. J Phys Chem Lett (2020) 0.75